【レポートの概要（一部）】
Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
1.3. List of Data Sources
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Home Healthcare Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Market Driver Analysis
3.3. Penetration & Growth Prospect Mapping
3.4. SWOT Analysis, By Factor
3.4.1. Political
3.4.2. Economic
3.4.3. Technological
3.5. Industry Analysis – Porter’s
Chapter 4. Home Healthcare Component Estimates & Trend Analysis
4.1. Home Healthcare Movement Analysis & Market Share, 2015 & 2025
4.2. Market Size Estimates & Forecasts and Trend Analyses, 2014 to 2025 (USD Billion) for the Following Components:
4.2.1. Equipment
4.2.1.1. Therapeutic
4.2.1.1.1. Home Respiratory Equipment
4.2.1.1.2. Insulin Delivery Device
4.2.1.1.3. Home IV Pumps
4.2.1.1.4. Home Dialysis Equipment
4.2.1.1.5. Other Therapeutic Equipment
4.2.1.2. Diagnostics
4.2.1.2.1. Diabetic Care Unit
4.2.1.2.2. BP Monitors
4.2.1.2.3. Multi Parameter Diagnostic Monitors
4.2.1.2.4. Home Pregnancy and Fertility Kits
4.2.1.2.5. Other Self-Monitoring Equipment
4.2.1.2.6. Apnea and Sleep Monitors
4.2.1.2.7. Holter Monitors
4.2.1.2.8. Heart Rate Maters
4.2.1.2.9. Other
4.2.1.3. Mobility Assists
4.2.1.3.1. Rehabilitation Services
4.2.1.3.2. Unskilled Home Care
4.2.1.3.3. Respiratory Therapy Services
4.2.1.3.4. Infusion Therapy Services
4.2.1.3.5. Telemetry
4.2.2. Services
4.2.2.1.1. Rehabilitation Services
4.2.2.1.2. Unskilled Home Care
4.2.2.1.3. Respiratory Therapy Services
4.2.2.1.4. Infusion Therapy Services
4.2.2.1.5. Telemetry
Chapter 5. Home Healthcare Regional Estimates & Trend Analysis
5.1. Regional Movement Analysis & Market Share, 2015 & 2025
5.2. North America
5.2.1. U.S.
5.2.1.1. U.S. revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.2.2. Canada
5.2.2.1. Canada revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.3. Europe
5.3.1. UK
5.3.1.1. UK revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.3.2. Germany
5.3.2.1. Germany revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.4. Asia Pacific
5.4.1. Japan
5.4.1.1. Japan revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.4.2. China
5.4.2.1. China revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.5. Latin America
5.5.1. Brazil
5.5.1.1. Brazil revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.5.2. Mexico
5.5.2.1. Mexico revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
5.6. MEA
5.6.1. South Africa
5.6.1.1. South Africa revenue estimates and forecasts by, component (USD Billion) 2014 – 2025
Chapter 6. Competitive Landscape
6.1. Strategy Framework
6.2. Company Profiles
6.2.1. Almost Family Inc.
6.2.1.1. Company Overview
6.2.1.2. Financial Performance
6.2.1.3. Product Benchmarking
6.2.1.4. Strategic Initiatives
6.2.2. B. Braun Melsungen AG
6.2.2.1. Company Overview
6.2.2.2. Financial Performance
6.2.2.3. Product Benchmarking
6.2.2.4. Strategic Initiatives
6.2.3. Abbott Laboratories
6.2.3.1. Company Overview
6.2.3.2. Financial Performance
6.2.3.3. Product Benchmarking
6.2.3.4. Strategic Initiatives
6.2.4. Sunrise Medical Inc.
6.2.4.1. Company Overview
6.2.4.2. Financial Performance
6.2.4.3. Product Benchmarking
6.2.4.4. Strategic Initiatives
6.2.5. 3M Healthcare
6.2.5.1. Company Overview
6.2.5.2. Financial Performance
6.2.5.3. Product Benchmarking
6.2.5.4. Strategic Initiatives
6.2.6. Baxter International Inc.
6.2.6.1. Company Overview
6.2.6.2. Financial Performance
6.2.6.3. Product Benchmarking
6.2.6.4. Strategic Initiatives
6.2.7. Medtronic
6.2.7.1. Company Overview
6.2.7.2. Financial Performance
6.2.7.3. Product Benchmarking
6.2.7.4. Strategic Initiatives
6.2.8. Cardinal Health Inc.
6.2.8.1. Company Overview
6.2.8.2. Financial Performance
6.2.8.3. Product Benchmarking
6.2.8.4. Strategic Initiatives
6.2.9. Roche Diagnostics Corp.
6.2.9.1. Company Overview
6.2.9.2. Financial Performance
6.2.9.3. Product Benchmarking
6.2.9.4. Strategic Initiatives
6.2.10. Roche Diagnostics Corp.
6.2.10.1. Company Overview
6.2.10.2. Financial Performance
6.2.10.3. Product Benchmarking
6.2.10.4. Strategic Initiatives
6.2.11. Roche Diagnostics Corp.
6.2.11.1. Company Overview
6.2.11.2. Financial Performance
6.2.11.3. Product Benchmarking
6.2.11.4. Strategic Initiatives
6.2.12. Air Liquide
6.2.12.1. Company Overview
6.2.12.2. Financial Performance
6.2.12.3. Product Benchmarking
6.2.12.4. Strategic Initiatives
6.2.13. Arcadia Resources, Inc.
6.2.13.1. Company Overview
6.2.13.2. Financial Performance
6.2.13.3. Product Benchmarking
6.2.13.4. Strategic Initiatives
6.2.14. Bayer Healthcare AG
6.2.14.1. Company Overview
6.2.14.2. Financial Performance
6.2.14.3. Product Benchmarking
6.2.14.4. Strategic Initiatives
6.2.15. Amedisys, Inc.
6.2.15.1. Company Overview
6.2.15.2. Financial Performance
6.2.15.3. Product Benchmarking
6.2.15.4. Strategic Initiatives
6.2.16. Nxstage Medical, Inc
6.2.16.1. Company Overview
6.2.16.2. Financial Performance
6.2.16.3. Product Benchmarking
6.2.16.4. Strategic Initiatives
6.2.17. Arkray Inc.
6.2.17.1. Company Overview
6.2.17.2. Financial Performance
6.2.17.3. Product Benchmarking
6.2.17.4. Strategic Initiatives
6.2.18. Apria Healthcare Group
6.2.18.1. Company Overview
6.2.18.2. Financial Performance
6.2.18.3. Product Benchmarking
6.2.18.4. Strategic Initiatives
6.2.19. Odyssey Healthcare Inc.
6.2.19.1. Company Overview
6.2.19.2. Financial Performance
6.2.19.3. Product Benchmarking
6.2.19.4. Strategic Initiatives
6.2.20. Becton, Dickinson and Company
6.2.20.1. Company Overview
6.2.20.2. Financial Performance
6.2.20.3. Product Benchmarking
6.2.20.4. Strategic Initiatives
6.2.21. Critical Homecare
6.2.21.1. Company Overview
6.2.21.2. Financial Performance
6.2.21.3. Product Benchmarking
6.2.21.4. Strategic Initiatives
6.2.22. National Healthcare Corp.
6.2.22.1. Company Overview
6.2.22.2. Financial Performance
6.2.22.3. Product Benchmarking
6.2.22.4. Strategic Initiatives
6.2.23. Omron Healthcare, Inc.
6.2.23.1. Company Overview
6.2.23.2. Financial Performance
6.2.23.3. Product Benchmarking
6.2.23.4. Strategic Initiatives
6.2.24. Drive Medical Design & Manufacturing
6.2.24.1. Company Overview
6.2.24.2. Financial Performance
6.2.24.3. Product Benchmarking
6.2.24.4. Strategic Initiatives
6.2.25. Chubb Community Care
6.2.25.1. Company Overview
6.2.25.2. Financial Performance
6.2.25.3. Product Benchmarking
6.2.25.4. Strategic Initiatives
6.2.26. Gambro AB
6.2.26.1. Company Overview
6.2.26.2. Financial Performance
6.2.26.3. Product Benchmarking
6.2.26.4. Strategic Initiatives
6.2.27. GE Healthcare
6.2.27.1. Company Overview
6.2.27.2. Financial Performance
6.2.27.3. Product Benchmarking
6.2.27.4. Strategic Initiatives
6.2.28. Medline Industries Inc.
6.2.28.1. Company Overview
6.2.28.2. Financial Performance
6.2.28.3. Product Benchmarking
6.2.28.4. Strategic Initiatives
6.2.29. Philips Healthcare
6.2.29.1. Company Overview
6.2.29.2. Financial Performance
6.2.29.3. Product Benchmarking
6.2.29.4. Strategic Initiatives
6.2.30. Medco Health Solutions Inc.
6.2.30.1. Company Overview
6.2.30.2. Financial Performance
6.2.30.3. Product Benchmarking
6.2.30.4. Strategic Initiatives
6.2.31. Graham-Field Health Products Inc.
6.2.31.1. Company Overview
6.2.31.2. Financial Performance
6.2.31.3. Product Benchmarking
6.2.31.4. Strategic Initiatives
6.2.32. Hill-Rom Holdings Inc.
6.2.32.1. Company Overview
6.2.32.2. Financial Performance
6.2.32.3. Product Benchmarking
6.2.32.4. Strategic Initiatives
6.2.33. Gentiva Health Services Inc
6.2.33.1. Company Overview
6.2.33.2. Financial Performance
6.2.33.3. Product Benchmarking
6.2.33.4. Strategic Initiatives
6.2.34. Johnson & Johnson
6.2.34.1. Company Overview
6.2.34.2. Financial Performance
6.2.34.3. Product Benchmarking
6.2.34.4. Strategic Initiatives
6.2.35. Linde Healthcare
6.2.35.1. Company Overview
6.2.35.2. Financial Performance
6.2.35.3. Product Benchmarking
6.2.35.4. Strategic Initiatives
6.2.36. Lincare Holdings, Inc.
6.2.36.1. Company Overview
6.2.36.2. Financial Performance
6.2.36.3. Product Benchmarking
6.2.36.4. Strategic Initiatives
6.2.37. Kinetic Concepts
6.2.37.1. Company Overview
6.2.37.2. Financial Performance
6.2.37.3. Product Benchmarking
6.2.37.4. Strategic Initiatives
6.2.38. Carefusion
6.2.38.1. Company Overview
6.2.38.2. Financial Performance
6.2.38.3. Product Benchmarking
6.2.38.4. Strategic Initiatives
6.2.39. Vygon
6.2.39.1. Company Overview
6.2.39.2. Financial Performance
6.2.39.3. Product Benchmarking
6.2.39.4. Strategic Initiatives
6.2.40. Teleflex
6.2.40.1. Company Overview
6.2.40.2. Financial Performance
6.2.40.3. Product Benchmarking
6.2.40.4. Strategic Initiatives
6.2.41. Moog Inc.
6.2.41.1. Company Overview
6.2.41.2. Financial Performance
6.2.41.3. Product Benchmarking
6.2.41.4. Strategic Initiatives
6.2.42. Intersurgical
6.2.42.1. Company Overview
6.2.42.2. Financial Performance
6.2.42.3. Product Benchmarking
6.2.42.4. Strategic Initiatives
6.2.43. Fresenius Kabi
6.2.43.1. Company Overview
6.2.43.2. Financial Performance
6.2.43.3. Product Benchmarking
6.2.43.4. Strategic Initiatives
【レポート販売概要】
■ タイトル：家庭用ヘルスケアの世界市場分析：コンポーネント別{機器（治療、診断、移動支援）}、サービス別（リハビリ、家族による在宅ケア、呼吸療法サービス、輸液療法サービス、テレメトリー）、セグメント予測、2014-2025■ 英文：Home Healthcare Market Analysis By Component {Equipment (Therapeutic, Diagnostic, Mobility Assist)}, Services (Rehabilitation, Unskilled Home Care, Respiratory Therapy Services, Infusion Therapy Services, Telemetry), And Segment Forecasts, 2014-2025
■ 発行日：2017年1月4日
■ 調査会社：Grand View Research
■ 商品コード：GVIEW707402
■ 調査対象地域：グローバル
- アメリカのオフィス向けコーヒー・サービス市場2016-2020About Office Coffee Service Office coffee services involve the installation of coffee vending machines in offices, maintained and supplied by various vendors, to ensure round-the-clock availability of coffee. The coffee machine is considered an important investment by employers. Office coffee services are considered to enhance employee productivity, and many employees like to view high-quality off …
- 世界のマイクロコントローラ市場分析：Analyzing the Global Market for MicrocontrollersA microcontroller is a small, single integrated circuit that can be found in many different kinds of devices such as automobiles, DVD players, digital cameras, iPods, consumer appliances, cell phones, wireless radios, RFID systems, and many other devices. Microcontrollers are also popularly found in the field of robotics these days. There are several microcontroller architectures and there are doz …
- Pompe Disease：グローバル臨床試験レビューH1, 2013Pompe Disease Global Clinical Trials Review, H1, 2013 Summary GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2013" provides data on the Pompe Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pompe Disease. It includes an overview of the trial numbers and their recruitment status as per the …
- フッ素系界面活性剤の世界市場：種類、用途、地域別市場分析The fluorosurfactants market size in terms of value is projected to grow at a CAGR of 5.1% between 2014 and 2019 to reach $364.1 million by 2019. North America held the largest share in fluorosurfactants market in 2013. Asia-Pacific is projected to register highest growth driven by the increasing consumptions of paint and coatings in architectural and automotive industries. Demand for paint and co …
- UV LEDの世界市場：タイプ別（UV A、UV B、UV C）、用途別（UV硬化、消毒/滅菌、屋内ガーデニング、偽造品検出など）、業種別（医療、農業、セキュリティ、印刷、住宅、商業）The global UV LED market size is expected to reach $1.2 billion by 2026 from 271.1 million in 2018, growing at a CAGR of 17.3% from 2018 to 2026. UV LED market is expected to leverage high potential for the manufacturing, security, printing, residential and Commercial industry verticals in 2026. The current business scenario is witnessing an increase in the demand for clean and safe hygienic envir …
- 世界のモバイル・ブロードバンド・モデム市場動向（2012-2016）TechNavio's analysts forecast the Global Mobile Broadband Modem Market to grow at a CAGR of 14.62 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high adoption of mobile devices. The Global Mobile Broadband Modem Market has also been witnessing availability of 3G and 4G supporting modems. However, the increasing availability of mobile hotspot rou …
- 殺生物剤の世界市場：ハロゲン化合物、金属化合物、有機硫黄化合物、有機酸、フェノール類Biocides are substances used to kill or inhibit all life forms when introduced in sufficient concentration and duration. Biocides are mostly used to kill harmful organisms and control bacterial or fungal growth. The biocides market is projected to register a CAGR of 4.8% between 2015 and 2020 to reach USD 10.6 billion, by 2020. Water treatment segment is estimated to be the largest application of …
- グローバル製薬業界における事業提携、ライセンシング、投資及びM&A動向：Q4 2013Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013 Summary GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2013” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&A) and financing in the pharmaceutical and healthcare market. The report provides …
- 食肉加工機械の世界市場予測（～ 2022）：カッティング機械、ブレンディング機械、テンダーライジング機械、フィリング機械、ダイシング機械、グラインディング機械、燻製機械The meat processing equipment is projected to grow at a CAGR of 7.03% from 2016 to 2022, to reach a projected value of USD 14.59 Billion by 2022. Meat processing equipment have become prominent in the recent years, due to the increase in the demand for various processed meat products, ready-to-eat, packaged meat products, and rise in safety regulations generating the need for sophisticated equipme …
- 医療用セラミックスの世界市場：生体不活性セラミックス、生体活性セラミックス、生体吸収性セラミックス、ピエゾセラミックスThe global market size of medical ceramics, in terms of value, is projected to reach USD 16.3 Billion by 2020, at a CAGR of 6.4% between 2015 and 2020. The high potential from the dental & orthopedic implants and increasing global demand for implantable electronic devices along with continuous expansion and merger & acquisition activities undertaken by different companies are the key factors for t …
- 世界主要国のアンチトロンビンIII検査（医療機器）市場The growing cost-containment pressures in major industrialized nations and continued technological advances will radically change coagulation testing practice during the next ten years. New specific and sensitive markers of hemostasis will be increasingly used on automated instrumentation. Coagulation testing in general, and AT III testing specifically, will become more standardized, offering oppo …
- スポーツテキスタイルの世界市場2019-2023Technavio Announces the Publication of its Research Report – Global Sportech Textiles Market 2019-2023 Technavio recognizes the following companies as the key players in the global sportech textiles market: DowDuPont, schoeller Switzerland, SKAPS Industries, Solvay, TORAY INDUSTRIES, INC.. Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the ma …
- 腫瘍治療薬の中国市場：化学療法、標的療法、免疫療法、ホルモン療法The China oncology drugs market was valued at $6,498.2 million in 2018 and is projected to reach $12,688.7 million by 2026, registering a CAGR of 8.7% from 2019 to 2026. Cancer is the second leading cause of death globally and is responsible for an estimated 9.6 million deaths in 2018. Globally, about 1 in 6 deaths is due to cancer according to the data published by WHO. Being the most populous co …
- 世界のホットドリンク（飲料）市場：ニュース、イベント動向（2014年3月）Synopsis The report provides a review of the latest news and key events in the global hot drinks market during March 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global hot drinks market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global …
- IoTセキュリティソフトウェアの世界市場2015-2019About IoT security IoT involve the communication of multiple devices within a network, which enables data transmission between smart devices such as thermostats and sensors that are further connected to mobile devices. In IoT, embedded software, hardware devices, communication services, and IT services are interconnected, which helps in remote monitoring and managing of numerous interconnected dev …
